UBS AM
AGN

UBS AM’s Allergan Inc AGN Stock Holding History

UBS AM’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,041,789
Closed -$221M – 2694
2014
Q4 		$221M Sell
1,041,789
-926,507
-47% -$184M 0.21% 112
2014
Q3 		$351M Buy
1,968,296
+202,671
+11% +$33.7M 0.35% 66
2014
Q2 		$299M Sell
1,765,625
-1,456,059
-45% -$227M 0.3% 72
2014
Q1 		$400M Buy
3,221,684
+71,744
+2% +$8.74M 0.43% 50
2013
Q4 		$350M Sell
3,149,940
-400,734
-11% -$38.3M 0.4% 54
2013
Q3 		$321M Sell
3,550,674
-602,460
-15% -$54.1M 0.4% 57
2013
Q2 		$350M Buy
+4,153,134
New +$431M 0.45% 47

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

UBS AM's AGN Position: Q1 2015 in Review

UBS AM sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,041,789 shares — an estimated $221M sold.

UBS AM first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $400M in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • UBS AM reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • UBS AM sold 1,041,789 Allergan Inc shares in Q1 2015, an estimated $221M.
  • UBS AM first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • UBS AM's Allergan Inc position peaked at $400M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on UBS AM's 13F filing for Q1 2015, filed 4 May 2015.